Repurposing lusutrombopag: unveiling anti-Staphylococcus aureus activity in a novel oral thrombopoietin receptor agonist. [PDF]
Li C +7 more
europepmc +1 more source
Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review. [PDF]
Namba K +4 more
europepmc +1 more source
Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial. [PDF]
Wu R +19 more
europepmc +1 more source
Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case Series. [PDF]
Wang SX +7 more
europepmc +1 more source
The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia. [PDF]
Li J +11 more
europepmc +1 more source
Systemic Lupus Erythematosus with Refractory Immune Thrombocytopenia Progressing to Catastrophic Anti-Phospholipid Syndrome During Thrombopoietin Receptor Agonist Therapy: A Case Report. [PDF]
Chung SW, Ha YJ.
europepmc +1 more source
The Establishment of a Novel Murine Model of Immune Thrombocytopenia in Pregnancy and the Impacts of Thrombopoietin Receptor Agonist on Platelet Production. [PDF]
Shibata S +9 more
europepmc +1 more source
Aplastic Anemia With Thrombosis Following the Administration of Immunosuppressant and Thrombopoietin Receptor Agonist (TPO-RA). [PDF]
Iino T, Yokoo M, Okamoto S, Kondo S.
europepmc +1 more source

